Kymera Therapeutics Inc. (KYMR)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

42.13

0.36%

After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	78.59M	46.83M	72.83M	34.03M	2.93M	-
Cost of Revenue	189.08M	2.98M	2.40M	62.10M	825.00K	205.00K
Gross Profit	-110.49M	43.85M	70.44M	-28.07M	2.11M	-205.00K
Operating Income	-165.53M	-161.26M	-100.53M	-46.30M	-42.20M	-21.45M
Interest Income	18.76M	6.62M	488.00K	826.00K	1.00M	-
Pretax Income	-146.96M	-154.81M	-100.22M	-45.59M	-41.25M	-21.47M
Net Income	-146.96M	-151.83M	-98.00M	-43.95M	-41.29M	-21.47M
Selling & General & Admin	55.04M	43.83M	36.34M	18.23M	7.98M	3.77M
Research & Development	189.08M	164.25M	137.02M	62.10M	37.16M	17.68M
Other Expenses	-	-	-	-	-	-
Operating Expenses	244.12M	208.08M	173.36M	80.34M	45.14M	21.45M
Interest Expense	196.00K	176.00K	175.00K	115.00K	46.00K	16.00K
Selling & Marketing Expenses	-	-	-	-	-	-
Cost & Expenses	244.12M	208.08M	173.36M	80.34M	45.14M	21.45M
Income Tax	-	-2.98M	-2.22M	-1.65M	46.00K	43.86K
Shares Outstanding (Basic)	58.37M	53.93M	47.99M	17.35M	44.53M	44.53M
Shares Outstanding (Diluted)	58.37M	53.93M	47.99M	17.35M	44.53M	44.53M
EPS (Basic)	-2.52	-2.82	-2.04	-2.53	-0.93	-0.48
EPS (Diluted)	-2.52	-2.82	-2.04	-2.53	-0.93	-0.48
EBITDA	-143.20M	-151.66M	-97.64M	-43.72M	-40.38M	-21.25M
Depreciation & Amortization	3.56M	2.98M	2.40M	1.76M	825.00K	205.00K